STEM Marketing joins Ashfield

STEM is a global business offering services across 35 countries including the US, EU, Japan and China and its customers include 18 of the top 20 largest pharmaceutical companies.  STEM’s unique service uses a proven, evidence based methodology to quantify and benchmark organisational alignment and quality of execution to create practical action plans to accelerate brand performance.
The acquisition significantly expands Ashfield’s service offering and capabilities in the commercial and clinical services market and complements Ashfield Healthcare Communications global offering. It is in line with UDG Healthcare’s strategy to grow both organically and via acquisition with a focus on high growth areas.
Commenting on the announcement, Brendan McAtamney, Chief Executive of UDG Healthcare plc said:
“STEM is an excellent strategic fit for UDG and is wholly aligned with our global growth strategy of expanding our market leading positions providing services to the pharmaceutical sector. The acquisition of STEM, a business with an established global footprint and strong growth opportunities, will enable us to provide new services to our clients, which are highly complementary to those already delivered by our Ashfield business.
We place great emphasis on cultural fit when looking at potential acquisition opportunities and STEM comes with an excellent management team, which will become an important part of our client offering and the wider UDG Healthcare Group.”
Commenting on...

Source: Ashfield Healthcare News - October 21, 2016 Category: Pharmaceuticals Authors: Josee Leach Tags: Ashfield Source Type: news